Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients

Background and aims: Vaccination for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is strongly recommended. The efficacy of SARS-CoV-2 vaccine for patients with end-stage renal disease is low. Indoxyl sulfate (IS) is a representative protein bound uremic toxin arousing immune dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yi-Chou, Wu, Chia-Lin, Lu, Kuo-Cheng, Kuo, Ko-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501048/
https://www.ncbi.nlm.nih.gov/pubmed/36146454
http://dx.doi.org/10.3390/vaccines10091378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501048/
https://www.ncbi.nlm.nih.gov/pubmed/36146454
http://dx.doi.org/10.3390/vaccines10091378

Ejemplares similares